2024 Research Articles

Related

• Italian guidelines for the management of irritable bowel syndrome in children and adolescents : Joint Consensus from the Italian Societies of: Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP), Pediatrics (SIP), Gastroenterology and Endoscopy (SIGE) and Neurogastroenterology and Motility (SINGEM)  PMID: 38486305
• Psychological distress in individuals with irritable bowel syndrome: the roles of body image and self-criticism. PMID: 38562654
• Characterization of the Small Bowel Microbiome Reveals Different Profiles in Human Subjects Who Are Overweight or Have Obesity  PMID: 38578969
• Functional Abdominal Bloating and Gut Microbiota: An Update  PMID: 39203511
  • Summary: This 12-study review found that “restoring a balanced microbiome appears to be the most promising solution” via “probiotics, prebiotics, antibiotics such as rifaximin or dietary modifications”, as well as “neuromodulators, and brain-gut behavioral therapies (i.e., cognitive-behavioral therapy)”.
• ​Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects  PMID: 39491051
• Food Retention at Endoscopy Among Adults Using Glucagon-Like Peptide-1 Receptor Agonists PMID: 39352703

Overview

• Small Intestinal Bacterial Overgrowth  PMID: 31536241
• Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS)  PMID: 38798120
• [SIBO, from myth to reality]  PMID: 39237384
• [Small intestinal bacterial overgrowth (SIBO) - Therapy, nutrition, microbiome]  PMID: 39208859

Causes/ Risk Factors 
Diseases

• Liquid Thyroxine Improves Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome  PMID: 38490469  PMID: 38490469
• Small Bowel Diverticulosis in an Elderly Patient Presenting With Obstruction and Intestinal Dysmotility: A Case Report  PMID: 39539876

Drugs/medication 

• A multi-national survey to identify clinicians' perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis  PMID: 38430623
• A Study on the Glucose Breath Test Positivity Rate and Occurrence of Small Intestine Bacterial Overgrowth-Related Symptoms Caused by Long-Term Use of Proton Pump Inhibitor (PPI) Versus Potassium-Competitive Acid Blocker (P-CAB) in Elderly Patients: SIBO Between PPI and P-CAB  PMID: 39502577
  • Summary: “Long-term use of gastric acid suppressants resulted in positive GBT [SIBO] in approximately 30% of patients, and the risk was particularly high in elderly patients. The occurrence of SIBO-related symptoms was significant in long-term use of PPIs and in patients with positive GBT.”

Surgery

• Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study  PMID: 38418752
• Prospective Monitoring of Small Intestinal Bacterial Overgrowth After Gastric Bypass: Clinical, Biological, and Gas Chromatographic Aspects  PMID: 38300481
• Blind Loop Syndrome  PMID: 36508549
• Modified Rosi-Cahill technique after left extended colectomy for splenic flexure advanced tumors  PMID: 39031212
• Use of Probiotics and Synbiotics in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) and Other Gastrointestinal Symptoms After Metabolic Bariatric Surgery: a Systematic Review and Meta-Analysis  PMID: 39607556

​

Pathophysiology

• Small intestinal microbiota: from taxonomic composition to metabolism  PMID: 38503579
• Small Intestine Bacterial Overgrowth is associated with increased Campylobacter and epithelial injury in duodenal biopsies of Bangladeshi children.    PMID: 38536881
• Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth  PMID: 38796441
• Intestinal Methanogen Overgrowth (IMO) Is Associated with Delayed Small Bowel and Colonic Transit Time (TT) on the Wireless Motility Capsule (WMC)  PMID: 39068378
• Identification of SIBO Subtypes along with Nutritional Status and Diet as Key Elements of SIBO Therapy  PMID: 39000446
• Symptom Profile of Patients With Intestinal Methanogen Overgrowth: A Systematic Review and Meta-analysis  PMID: 39147218
  • Summary: Review of 19 studies analyzing symptoms present in those with IMO (Methane-SIBO)
    • bloating (78%)
    • constipation (51%)
    • diarrhea (33%)
    • abdominal pain (65%)
    • nausea (30%)
    • flatulence (56%)
• ​Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model  PMID: 38108386

Associated Conditions

• Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases-Current State of Knowledge  PMID: 38790992​

Alzheimer

• Association between small intestine bacterial overgrowth and psychiatric disorders  PMID: 39497810
  • Summary: “These findings highlight the importance of tryptophan metabolism in the gut-brain axis and suggest that addressing SIBO and its impact on tryptophan metabolism could be a potential therapeutic avenue for managing and understanding these complex disorders [Parkinson’s and Alzheimer’s disease, depression, schizophrenia, and autism spectrum disorder].

Autism

• Association between small intestine bacterial overgrowth and psychiatric disorders  PMID: 39497810
  • Summary: “These findings highlight the importance of tryptophan metabolism in the gut-brain axis and suggest that addressing SIBO and its impact on tryptophan metabolism could be a potential therapeutic avenue for managing and understanding these complex disorders [Parkinson’s and Alzheimer’s disease, depression, schizophrenia, and autism spectrum disorder].

Brain Fog

• Brain Fog in Gastrointestinal Disorders: Small Intestinal Bacterial Overgrowth, Gastroparesis, Irritable Bowel Syndrome  PMID: 39495803

Children (Pediatric)

• Factors associated with D-lactic acidosis in pediatric intestinal failure: A case-control study  PMID: 38374557
• Assessment of Biochemical, Inflammatory Biomarkers and Ultra-Processed Food Consumption in Children with Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study  PMID: 39125359
• Pediatric Chronic Intestinal Failure: Something Moving?  PMID: 39275281

Cystic Fibrosis

• The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis  PMID: 39105345

Dental/Oral Health

• Oral Health and "Modern" Digestive Diseases: Pathophysiologic and Etiologic Factors  PMID: 39200318

Depression

• Association between small intestine bacterial overgrowth and psychiatric disorders  PMID: 39497810
  • Summary: “These findings highlight the importance of tryptophan metabolism in the gut-brain axis and suggest that addressing SIBO and its impact on tryptophan metabolism could be a potential therapeutic avenue for managing and understanding these complex disorders [Parkinson’s and Alzheimer’s disease, depression, schizophrenia, and autism spectrum disorder].

Diabetes

• Small intestinal bacterial overgrowth in diabetic gastroenteropathy  PMID: 38651669  

Diverticulosis

• Small Bowel Diverticulosis in an Elderly Patient Presenting With Obstruction and Intestinal Dysmotility: A Case Report  PMID: 39539876

Gastric Bypass

• Prospective Monitoring of Small Intestinal Bacterial Overgrowth After Gastric Bypass: Clinical, Biological, and Gas Chromatographic Aspects  PMID: 38300481
• Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study  PMID: 38418752
• Use of Probiotics and Synbiotics in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) and Other Gastrointestinal Symptoms After Metabolic Bariatric Surgery: a Systematic Review and Meta-Analysis  PMID: 39607556

​GERD

• The Lactulose Breath Test Can Predict Refractory Gastroesophageal Reflux Disease by Measuring Bacterial Overgrowth in the Small Intestine  PMID: 38896424
• Impacts of intestinal fermentation on gastroesophageal reflux disease: can the tail wag the dog?  PMID: 39573864

Halitosis NEW

• Therapeutic efficacy of a probiotic preparation on idiopathic halitosis: a retrospective observational study  PMID: 39496205
  • Summary: “Our findings suggest that idiopathic halitosis is an extra-oral condition which mostly originates from the small intestine. SIBO is one of its underlying causes. The probiotic preparation [Bifidobacterium triple viable capsule for two months] can effectively improve idiopathic halitosis, probably through its impact on SIBO.”

H. pylori

• Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability  PMID: 38166953
• Influence of Helicobacter pylori Infection and Eradication on Small Intestinal Bacterial Overgrowth and Abdominal Symptoms  PMID: 38363519

Hypothyroid

• Liquid Thyroxine Improves Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome PMID: 38490469

IBD (Inflammatory Bowel Disease)

• The Association of Extra-oral Halitosis With Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease  PMID: 38696141
• Anti-CdtB and anti-vinculin antibodies to diagnose irritable bowel syndrome in inflammatory bowel disease patients   PMID: 39627697

IBS (Irritable Bowel Syndrome)

• The IBS and SIBO dilemma: Here we go again  PMID: 39218737
• Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth  PMID: 39043536

Intestinal Failure (pediatric)

• Factors associated with D-lactic acidosis in pediatric intestinal failure: A case-control study  PMID: 38374557
• Are enteral devices risk factors for central line-associated bloodstream infections in children with intestinal failure?  PMID: 39742591

Lactose Malabsorption

• Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth  PMID: 39641896

Liver Disease

• Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study  PMID: 38337613
• Dysbiosis and nutrition in steatotic liver disease: addressing the unrecognized small intestinal bacterial overgrowth (SIBO) challenge  PMID: 38499938
• Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study  PMID: 38854668
• Impact of small intestinal bacterial overgrowth on systemic inflammation, circulatory and renal function, and liver fibrosis in patients with cirrhosis and ascites  PMID: 38779647
• MASLD can cause halitosis by small intestinal bacterial overgrowth  PMID: 38764349
• Small intestinal bacterial overgrowth and metabolic dysfunction-associated steatotic liver disease PMID: 39742106
  • Summary: “this meta-analyses provides strong evidence that SIBO may contribute to the development and progression of MASLD [Metabolic-Associated Steatotic Liver Disease].”

Parkinson’s

• Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability  PMID: 38166953
• A review of the gastrointestinal, olfactory, and skin abnormalities in patients with Parkinson's disease  PMID: 38195133
• Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease  PMID: 38729797
• The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications  PMID: 38570412
• Association between small intestine bacterial overgrowth and psychiatric disorders  PMID: 39497810
  • Summary: “These findings highlight the importance of tryptophan metabolism in the gut-brain axis and suggest that addressing SIBO and its impact on tryptophan metabolism could be a potential therapeutic avenue for managing and understanding these complex disorders [Parkinson’s and Alzheimer’s disease, depression, schizophrenia, and autism spectrum disorder].
• Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases  PMID: 37851313

Rosacea

• Evaluation of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Subjects With Rosacea  PMID: 39583431

Systemic Sclerosis

• [Severe small bowel involvement and chronic intestinal pseudo-obstruction in systemic sclerosis (scleroderma): Pathophysiological, diagnostic and therapeutic basis, including parenteral nutrition]  PMID: 38388303
• Diffuse Gastrointestinal Motor Compromise in Patients with Scleroderma: Utility of Minimally Invasive Techniques  PMID: 37982941
• A multi-national survey to identify clinicians' perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis  PMID: 38430623

Thyroid

• Evaluation of the therapeutic efficacy of different doses of LT4 in pregnant women with high-normal TSH levels and TPOAb positivity in the first half of pregnancy  PMID: 38600581

Testing

• Gastric, small bowel and colonic motility and breath-testing  /doi.10.1016/j.mpmed.2024.01.004​
• Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS)  PMID: 38798120
• Small Intestinal Bacterial Overgrowth (SIBO), a clinically overdiagnosed entity?  PMID: 38719183
• Glucose breath test for the detection of small intestine bacterial overgrowth: Impact of diet prior to the test  PMID: 38606691
• Capsules for the Diagnosis and Treatment of Gastrointestinal Motility Disorders- A Game Changer  PMID: 38630422
• Detection capacity of small intestine bacterial or methanogen overgrowth by lactose and fructose breath testing in the adult population  PMID: 39252801
• Validation of a Hand-Held Point-of-Care Device to Measure Breath Hydrogen and Its Utility in Detecting Response to Antibiotic Treatment  PMID: 39127844
  • Summary: This study compared FoodMarble AIRE® to existing mail-in kits in patients suspected to have SIBO.
    Results: “Substantial agreement was demonstrated between AIRE and the mail-in kits for the performance of lactulose hydrogen breath tests.”
• ​Evaluation of a Novel Smart Capsule Bacterial Detection System Device for Diagnosis of Small Intestinal Bacterial Overgrowth  PMID: 39587802
  • Summary: “These results demonstrate the potential utility of SCBDS [smart capsule bacterial detection system] device to aid SIBO diagnosis as a simple and non-invasive tool that merits further clinical validation.”
• The prevalence of small intestine bacterial overgrowth in irritable bowel syndrome is much higher with lactulose than glucose breath test: Results of a retrospective monocentric study  PMID: 39426620

Methane

• The Lactulose Breath Test Can Predict Refractory Gastroesophageal Reflux Disease by Measuring Bacterial Overgrowth in the Small Intestine  PMID: 38896424

​Treatment 

• Common questions and rationale answers about the intestinal bacterial overgrowth syndrome (SIBO)  PMID: 38852778
• The importance of food quality, gut motility, and microbiome in SIBO development and treatment  PMID: 38657418

Antibiotics

• Antibiotics for Dyspepsia: Hp, SIBO, IMO, or Something Else?  PMID: 38363520
• Symptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysis  PMID: 38173154
• Amoxicillin Clavulanate  PMID: 30844191
  • Summary: “the efficacy of amoxicillin-clavulanate in treating SIBO approximates 50%”
• Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review  PMID: 39041415
• Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial  PMID: 39103611
  • Summary: (rat study) “poor solubility [of Rifaximin] may limit its efficacy against microbes in the mucus layer, e.g. Escherichia coli. Here we evaluate adding the mucolytic N-acetylcysteine (NAC) to improve rifaximin efficacy.  …combining rifaximin with NAC had significant synergistic effects in reducing E. coli levels.”
    Dr. Pimentel and I discuss the “special formulation” of NAC that he used in a recent interview. Watch it Here (NAC discussion is at 1:21 hours, study results at 20:34 min)
• Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth  PMID: 39641896
• Rifaximin  PMID: 30000968
• Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin  PMID: 39443798
• A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome PMID: 39476291
  • Summary: This study used a higher dose of Rifaximin, 2200mg x 10 days vs the standard SIBO dose of 1650 mg/d x 14 days, for IBS-diarrrhea (SIBO was not tested), which resulted in significant improvement in symptoms, no serious adverse effects, and 94.9% adherence rate.

Rifaximin

• Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs  PMID: 38366822
• Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial  PMID: 38576371

Trimebutine Maleate

• Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial  PMID: 38576371  

Herbal Antibiotics

• Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial  PMID: 38613116

Elemental Diet

• Elemental Diet as a Therapeutic Modality: A Comprehensive Review  PMID: 39001958

Fecal Microbiota Transplantation (FMT)

• The impact of small intestinal bacterial overgrowth on the efficacy of fecal microbiota transplantation in patients with chronic constipation  PMID: 39194187

Probiotics

• Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial  PMID: 38613116
• Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study  PMID: 38418752
• Probiotics and Prebiotics in Subclinical Hypothyroidism of Pregnancy with Small Intestinal Bacterial Overgrowth  PMID: 37032411
• Therapeutic efficacy of a probiotic preparation on idiopathic halitosis: a retrospective observational study  PMID: 39496205
  • Summary: “Our findings suggest that idiopathic halitosis is an extra-oral condition which mostly originates from the small intestine. SIBO is one of its underlying causes. The probiotic preparation [Bifidobacterium triple viable capsule for two months] can effectively improve idiopathic halitosis, probably through its impact on SIBO.”
• Use of Probiotics and Synbiotics in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) and Other Gastrointestinal Symptoms After Metabolic Bariatric Surgery: a Systematic Review and Meta-Analysis  PMID: 39607556 

Prokinetics

• Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study  PMID: 38337613
• Clinical outcomes before and after prucalopride treatment: an observational study in patients with chronic idiopathic constipation in the USA  PMID: 38357940
• Safety and Effectiveness of Prucalopride in Children with Functional Constipation with and without Upper Symptoms  PMID: 38175354
• Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double-blind, placebo control clinical trial  PMID: 38361151
• 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy  PMID: 38638303

• Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial  PMID: 39109752
  • Summary: “Treatment with prucalopride was associated with significantly lower incidence of depression … Significantly lower risks of all mood disorders and psychosis were also observed. … These findings support preclinical data and suggest a role for 5-HT4R agonists [prucalopride] as novel agents in the prevention of major depression.”
• Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA Adverse Event Reporting System (FAERS) database  PMID: 38995209
  • Summary: “Analysis of 865 reports [of adverse events] on prucalopride revealed
    • headache (n = 120, 13.9%)
    • diarrhea (n = 116, 13.4%)
    • abdominal pain (n = 100, 11.6%)
    • dystonia (n=22, 2.5%)”
• Prokinetic effect of erythromycin in the management of gastroparesis in critically ill patients-our experience and literature review  PMID: 39314225

Diet

• Food Intolerances, Food Allergies and IBS: Lights and Shadows  PMID: 38257158
• The Role of Diet in the Management of Irritable Bowel Syndrome: A Comprehensive Review  PMID: 38496157
• [Small intestinal bacterial overgrowth (SIBO) - Therapy, nutrition, microbiome]  PMID: 39208859

Diet: FODMAP Diet

• The Role of the FODMAP Diet in IBS  PMID: 38337655
• Alterations in gut microbiota caused by major depressive disorder or a low FODMAP diet and where they overlap  PMID: 38260072
• Can we predict who will respond to a low-FODMAP diet in irritable bowel syndrome?  PMID: 38238032
• Nutrition and Disorders of Gut-Brain Interaction  PMID: 38202005
• Effect of fibre fortification of low FODMAP pasta  PMID: 38225882
• Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome  PMID: 38401741
• Fructan Concentrations in Cooked Cereal Grains as a Nutritional Consideration for Low-FODMAP Diet  PMID: 38257195
• Quality characteristics of cereal-based foods enriched with different degree of polymerization inulin: A review  PMID: 38431396
• Diet low in fodmaps: fundamentals, evidence and controversies  PMID: 38493009
• Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome- a double-blind randomized cross-over challenge study  PMID: 38347192
• Fructose malabsorption and fructan malabsorption are associated in patients with irritable bowel syndrome  PMID: 38654193
• Effect of the Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet on Control of Pediatric Irritable Bowel Syndrome and Quality of Life Among a Sample of Egyptian Children: A Randomized Controlled Clinical Trial.  PMID: 38910620
• The low-FODMAP diet PMID: 38906802
• Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis.  PMID: 38892659  
• Is the Mediterranean Low Fodmap Diet Effective in Managing Irritable Bowel Syndrome Symptoms and Gut Microbiota? An Innovative Research Protocol.  PMID: 38892525
• A diet low in fermentable oligo-, di-, monosaccharides and polyols improves abdominal and overall symptoms in persons with all subtypes of irritable bowel syndrome.  PMID: 38887150  
• Unveiling the dynamics of gut microbial interactions: a review of dietary impact and precision nutrition in gastrointestinal health.  PMID: 38873568 
• [Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet].  PMID: 38809220
• Causative Factors, Clinical Manifestations, and Therapeutic Strategies for Irritable Bowel Syndrome.  PMID: 38779277
• Evolution, adaptation, and new applications of the FODMAP diet.  PMID: 38770353
• The efficacy and real-world effectiveness of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome: A systematic review and meta-analysis.  PMID: 38754307  
• Global research trend and hotspot in the low FODMAP diet: a bibliometric analysis.  PMID: 38741213
• Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results from a Double-Blind, Pilot Randomized Controlled Trial.  PMID: 38729393
• All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome.  PMID: 38729390
• A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome.  PMID: 38717025
• Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: a systematic umbrella review with the meta-analysis of clinical trials.  PMID: 38711328
• Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome.  PMID: 38689453
• Coffee, Alcohol, and Artificial Sweeteners Have Temporal Associations with Gastrointestinal Symptoms.  PMID: 38662159
• Production, modification and degradation of fructans and fructooligosacharides by enzymes originated from plants.  PMID: 38649077
• Managing irritable bowel syndrome: balancing diet and pharmacotherapy.  PMID: 38643783
• A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.  PMID: 38643782
• Efficacy of a Low-FODMAP Diet for Coeliac Patients with Persistent IBS-like Symptoms despite a Gluten-Free Diet: A Systematic Review.  PMID: 38613127
• Low-FODMAP diet on postprandial distress syndrome type of functional dyspepsia with mixed type of irritable bowel syndrome patient: A case report  PMID: 39280305
• A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS-A Randomized Non-Inferiority Study  PMID: 39275354
• Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet  PMID: 39203842
• Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome  PMID: 39173527
• Patients' experiences of dietary changes during a structured dietary intervention for irritable bowel syndrome  PMID: 39138906
• Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials  PMID: 39110917
• DOMINO trial post hoc analysis: evaluation of the diet effects on symptoms in IBS subtypes  PMID: 39086991
• Predictors of response to a dietary intervention in patients with irritable bowel syndrome  PMID: 39029788
• Sourdough Bread Quality: Facts and Factors  PMID: 38998638
• Predicting Response to Low Fermentable Oligo-, Di-, Mono-saccharides, and Polyols Diet in Patients With Abdominal Bloating Using Hydrogen Methane Breath Test: Is a Spot Sample Enough?  PMID: 38972871
• FODMAP Diet in Celiac Disease and Gluten-Related Disorders.  PMID: 39683583
• Low FODMAP diets-Boon or bane for individuals with GI disorders.  PMID: 39529351
• Gut-Brain Axis and Psychopathology: Exploring the Impact of Diet with a Focus on the Low-FODMAP Approach.  PMID: 39458509
• Use of Carbohydrate (CHO), Gluten-Free, and FODMAP-Free Diets to Prevent Gastrointestinal Symptoms in Endurance Athletes: A Systematic Review.  PMID: 39599638
• Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes.  PMID: 39408383
• Efficacy and Safety of a Low-FODMAP Diet in Combination with a Gluten-Free Diet for Adult Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.  PMID: 39407084
• A service evaluation of FODMAP restriction, FODMAP reintroduction and long-term follow-up in the dietary management of irritable bowel syndrome.  PMID: 39498596
• Dietary management of irritable bowel syndrome: considerations, challenges, and solutions.  PMID: 39521003
• Practices and Barriers in Implementing the Low FODMAP Diet for Irritable Bowel Syndrome Among Malaysian Dietitians: A Qualitative Study.  PMID: 39519430 
• Comparison of 4-week versus 8-week dietitian-led FODMAP diet group education sessions in tertiary care clinical practice for irritable bowel syndrome: A service evaluation  PMID: 39380330
• Gluten-Free Diet for Fashion or Necessity? Review with New Speculations on Irritable Bowel Syndrome-like Disorders.  PMID: 39683629
• Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome.  PMID: 39392338